CV Sciences Inc (CVSI)

[lazur]

What I'll be looking at is detail on this explanation in the ER call:

Second quarter sales were impacted by the current COVID-19 pandemic and increased market competition, which is largely due to the uncertain regulatory environment for CBD. The Company's retail store count increased to 6,325 stores nationwide as of June 30, 2020, up from 4,591 stores as of June 30, 2019.

COVID-19 is affecting CVSI and its competitors equally - that may lead to a drop in earnings, but that drop if all else is equal should be the same for their competitors. When it's not equal, that's an indication the competition is beating them in gaining market share in a difficult market.

The regulatory environment - same, affects all equally.

Increased competition, again, that's for total CDB dollars among the companies. Need to look at competitors and see if they have proportional reductions in revenue of if they are doing better than CVSI. If better, then what's CVSI management's reason for being a laggard, if CVSI is better than other competitors, how will they expand on that and break further from the pack. the recent announcements could lead to that, but the real detail is in the comparison to competitors.